The 10-day RSI Indicator for BFLY moved out of overbought territory on December 12, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 instances where the indicator moved out of the overbought zone. In of the 16 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on December 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on BFLY as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BFLY turned negative on December 05, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .
BFLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 91 cases where BFLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.984) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.241) is also within normal values, averaging (43.338).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DURPX | 24.68 | 0.31 | +1.27% |
DFA US Hi Relatv Profitability Instl | |||
GUMPX | 21.69 | N/A | N/A |
NAA Market Neutral Real Estate P | |||
GGGPX | 39.58 | N/A | N/A |
Goldman Sachs Large Cap Core P | |||
HLGZX | 33.91 | N/A | N/A |
Harding Loevner Global Equity Instl Z | |||
PAXGX | 16.33 | -0.30 | -1.80% |
Impax Global Opportunities Investor |
A.I.dvisor indicates that over the last year, BFLY has been loosely correlated with CTKB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BFLY jumps, then CTKB could also see price increases.
Ticker / NAME | Correlation To BFLY | 1D Price Change % | ||
---|---|---|---|---|
BFLY | 100% | +4.04% | ||
CTKB - BFLY | 42% Loosely correlated | +2.26% | ||
FLGT - BFLY | 39% Loosely correlated | -2.19% | ||
MASS - BFLY | 38% Loosely correlated | +5.93% | ||
BLFS - BFLY | 37% Loosely correlated | +4.83% | ||
HBIO - BFLY | 36% Loosely correlated | +0.24% | ||
More |